Director of Fetal Medicine Unit, Liverpool Women's Hospital
Vice-President of Royal College of Obstetricians and Gynaecologists

Asma Khalil is a Professor of Fetal Medicine. She is the Obstetric Lead at the National Maternity and Perinatal Audit (NMPA). She gained her MD at the University of London in 2008.

Prof. Asma Khalil has published more than 500 peer-reviewed papers, and many published review articles and chapters. She has been awarded many research prizes, both at national and international meetings. She was awarded the 2021 FIGO Women's Awards: Recognising Female Obstetricians and Gynaecologists. Her research interests include twin pregnancy, congenital infections, fetal growth restriction and hypertensive disorders in pregnancy.

She had a fellowship with the National Institute of Health and Care Excellence (NICE) and is committed to the implementation of clinical guidelines in practice. She is the Lead author of the ISUOG guideline on the role of ultrasound in twins and congenital infections. She also led the guideline team developing the FIGO guideline on twin pregnancies. She was a member of the NICE Guideline Committee updating the Twin and Multiple Pregnancy guidance.

Visiting Professor at King's College, London
Consultant in Fetal Medicine at Birmingham Women's and Children's Foundation Trust

Professor Kilby has practiced Fetal Medicine and therapy in the United Kingdom for 28 years. In the last 15 years, one of his 'pillars' of research was investigating the application and clinical utility of new genomic technologies in prenatal diagnosis. He was a Principal investigator (PI) on the Wellcome Trust-funded Prenatal Assessment of Genomes and Exomes (PAGE) study which involved the feasibility, diagnostic accuracy and utility, patient acceptability and health economics of the prenatal application of exome sequencing in the fetal with congenital malformations. He was also the PI on the Percutaneous insertion of shunts in lower urinary Tract obstruction RCT (published in the Lancet, 2015).

He was Chair of the Royal College of Obstetricians and Gynaecologists (RCOG) Genomic Taskforce (2019-2024) and is a member of the Joint Colleges Committee of Genomic Medicine, and a member of the Genomics England, Newborn Screening group for the 'Generation Study' Implementation Group.

For two years, he was a Senior Principal Clinical Scientist at the Medical Genomics Research Group at Illumina, Cambridge, UK (2022-2024). He continues to work as a clinician in the Joint Fetal Medicine /Genetics Clinic, in Birmingham, UK.

He was Clinical Lead in Fetal Medicine and Therapy at the Birmingham and West Midlands Fetal Medicine Centre, at Birmingham Women's & Children's Foundation Trust from 1995–2022 and Dame Hilda Lloyd Chair of Fetal Medicine for the same period. During this time, he was involved in all aspects of Fetal Medicine and Therapy, leading the tertiary centre that provided much of the complex fetal therapy care for the Midlands and the North of England.

Donna Ockenden is a nurse and a midwife. She has more than 35 years' experience within a variety of health settings both in the UK and internationally.

In 2017 Donna was appointed to chair the Independent review into Maternity Services at the Shrewsbury and Telford Hospitals NHS Trust, the final report of which was published on 30 March 2022.

Donna has been a champion of patient safety in women's and children's health and maternity services - she works alongside a number of charities who are committed to ensuring the best and safest outcomes for mothers and their babies, including Baby Lifeline, Sands and MASIC.

In May 2022, Donna was appointed as the Chair of the Independent review into Maternity Services at the Nottingham University Hospitals NHS Trust, which is expected to publish in September 2025.